Searched for
INDIA PHARMA CONFERENCE
For investors with ability – and patience to wait 3 years, not 3 months: 6 large-cap stocks with upside potential of up to 33%The interesting point about the large-cap space today is not that prices have collapsed. In most cases, they have not. The more important c...
India Pharma 2026 event: Nadda lays out road map for India to take global pharma leadership roleIndia Pharma Conference: India is set to become a global leader in advanced medicines like biologics and biosimilars, Union Minister J P Na...
If West Asia crisis continues Indian exports to other parts of world will get impacted: OfficialIndia's trade relations are being tested by the escalating conflict in West Asia. According to Commerce Secretary Rajesh Agrawal, the crisi...
Govt mulling policy to boost manufacturing of patented drugs: Mansukh MandaviyaToday, India has the highest number of generic medicine manufacturing companies with more than 3,500 pharma firms and 10,500 manufacturing ...
Panel to meet today to take up applications seeking nod for MolnupiravirThe firms whose applications that will be taken up are Dr Reddy's Laboratories which has filed for approval in a consortium with five other...
Indian pharma market expected to hit USD 130 billion by 2030: Sadananda GowdaPharmaceuticals are one of the top-10 attractive sectors for foreign investment in India. FDI inflows in the pharmaceuticals sector reached...
Can't directly deal with complaints of unethical practices: Department of pharmaceuticalsDoP also asked pharma associations to submit compliance report and form committees to look into action taken on the complaints. Pharma lobb...
HR fraternity underscores safety, using stress positivelySuresh said CXO-level hiring has been impacted butthere are specific sectors - pharma, ecommerce, chemicals and technology - where hiring w...
Pharma companies must adhere to marketing norms during conferences: GovtAsking the lobbies to ensure that no unethical promotion of pharma products is done during conferences, it said companies must adhere to th...
Why Sun Pharma is under a cloud: Decoding Aditya Medisales linkA purported whistleblower letter has highlighted Sun Pharma's dealings with subsidiary AML.
Pharma stocks gain amid govt's plans to crackdown on marketing by drug makersThe Nifty Pharma index emerged as the top gainer on NSE.
Pharma and Med Tech Zone to be set up soon at Bengaluru: Ananth KumarIndia's pharma sector, which has achieved a Compounded Annual Growth Rate (CAGR) of over 15%, would be worth $55 billion by 2020.
Prefer Torrent Pharma in midcap pharma space; see stock at Rs 1,677: Daljeet Singh KohliTorrent Pharma Q1 numbers were ahead of expectations, although some people have raised questions over what is next, says Kohli.
India seeks cooperation in pharma from JapanKher said that Indian medicines are affordable and of top quality as it meets the requirement of the toughest regulatory markets in the US ...
Egypt seeks investment from Indian pharma playersThe focal point to export to the whole Mena region will be a win-win situation for both sides and we will do our best to help this push, Am...
Cabinet defers consideration of pharma, housing FDI proposalsThe Cabinet today deferred the consideration of proposals to relax foreign direct investment norms in the housing sector and to reduce the ...
- India may surpass China in GDP growth in 10 yrs: Nirmal Jain
India still keeps chugging along and is now moving at 8.5-9% per annum which is one of the fastest growth rates, says Nirmal Jain, Chairman...
- Global Pharma looks to India for pain relief
With the global pharma companies cutting back on costs, letting go of people and shutting down plants in large markets, the crisis is palpa...
- Global Bio-Pharma Conference 2006 begins
The Bio Pharma Industry should concentrate on tackling the emerging tropical and viral diseases, Andhra Pradesh chief minister Y S Rajasekh...
- 'India's WTO compliance threatens AIDS drugs'
A protest erupted at a global AIDS conference Tuesday over India's compliance with WTO drug patent rules which critics charge could leave t...